Media coverage
8
Media coverage
Title iECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506 Media name/outlet International Business Times Australia Country/Territory Australia Date 13/12/23 Persons George Diaz Title iECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506 Media name/outlet Business Wire Country/Territory United States Date 13/12/23 URL ct.moreover.com/?a=52575917604&p=1gw&v=1&x=5mbW_xUDWw87AYveZrB4AA Persons George Diaz Title iECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506; ECUR-506 is a gene editing-based investigational therapy for the treatment of Ornithine Transcarbamy Media name/outlet Business Wire Country/Territory United States Date 13/12/23 Persons George Diaz Title iECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506 Media name/outlet BioSpace Country/Territory United States Date 13/12/23 URL ct.moreover.com/?a=52576149853&p=1gw&v=1&x=nNDhp0Q7C5b7JCE0tRuspg Persons George Diaz Title iECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506 Media name/outlet Yahoo! Finance Country/Territory United States Date 13/12/23 URL ct.moreover.com/?a=52576018121&p=1gw&v=1&x=R-gle20rxyrzDV5WqKrYsw Persons George Diaz Title iECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506 Media name/outlet Chase Country/Territory United States Date 13/12/23 URL ct.moreover.com/?a=52575871780&p=1gw&v=1&x=-UzRaZnU_n3PR8TXuA31sA Persons George Diaz Title iECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506 Media name/outlet Le Lezard.com Country/Territory Canada Date 13/12/23 URL ct.moreover.com/?a=52575977052&p=1gw&v=1&x=7Z7GvfY_hw2gOilygfFwgQ Persons George Diaz Title iECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506 Media name/outlet Daily Item Country/Territory United States Date 13/12/23 URL ct.moreover.com/?a=52576017839&p=1gw&v=1&x=FfZbzIDNkEbQt6naBvxenw Persons George Diaz